Advanced search
Publication Cover
Acta Oncologica Volume 59, 2020 - Issue 6
Journal homepage
1,641
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: BIOMARKERS

Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma

Jon Røikjaer HenriksenDepartment of Oncology, University Hospital of Southern Denmark, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-2905-5342View further author information
ORCID Icon,
Frede DonskovDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark; View further author information
,
Marianne WaldstrømInstitute of Regional Health Research, University of Southern Denmark, Odense, Denmark; ;Department of Pathology, University Hospital of Southern Denmark, Vejle, DenmarkView further author information
,
Anders JakobsenDepartment of Oncology, University Hospital of Southern Denmark, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; View further author information
,
Mette HjortkjaerDepartment of Oncology, University Hospital of Southern Denmark, Vejle, Denmark; View further author information
,
Christina Braad PetersenDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark; View further author information
&
Karina Dahl SteffensenDepartment of Oncology, University Hospital of Southern Denmark, Vejle, Denmark; ;Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; ORCID Iconhttp://orcid.org/0000-0002-9217-3907View further author information
ORCID Icon show all
Pages 652-659 | Received 01 Nov 2019, Accepted 26 Dec 2019, Published online: 14 Jan 2020

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jon Røikjær Henriksen, Line Nederby, Frede Donskov, Marianne Waldstrøm, Parvin Adimi, Anders Jakobsen & Karina Dahl Steffensen. (2020) Blood natural killer cells during treatment in recurrent ovarian cancer. Acta Oncologica 59:11, pages 1365-1373.
Read now

Articles from other publishers (24)

Sarah Nersesian, Riley J. Arseneau, Jorge P. Mejia, Stacey N. Lee, Lauren P. Westhaver, Nigel W. Griffiths, Stephanie R. Grantham, Liliane Meunier, Laudine Communal, Avik Mukherjee, Anne-Marie Mes-Masson, Thomas Arnason, Brad H. Nelson & Jeanette E. Boudreau. (2024) Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages. Frontiers in Immunology 14.
Crossref
Jeongwan Kang, Kang Min Han, Hera Jung & Hyunchul Kim. (2023) Prognostic Significance of Programmed Cell Death Ligand 1 Expression in High-Grade Serous Ovarian Carcinoma: A Systematic Review and Meta-Analysis. Diagnostics 13:20, pages 3258.
Crossref
Ye-Min Wang, Wei Cai, Qing-Ming Xue, Jin-Yao Zhang, Lv Zhou, Su-Yi Xiong & Huan Deng. (2023) Prognostic role of different PD-L1 expression patterns and tumor-infiltrating lymphocytes in high-grade serous ovarian cancer: a systematic review and meta-analysis. Frontiers in Immunology 14.
Crossref
Daniel Margul, Camilla Yu & Mariam M. AlHilli. (2023) Tumor Immune Microenvironment in Gynecologic Cancers. Cancers 15:15, pages 3849.
Crossref
Pavan Kumar, Samruddhi Ranmale, Sanket Mehta, Hemant Tongaonkar, Vainav Patel, Amit Kumar Singh & Jayanti Mania-Pramanik. (2023) Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. Journal of Ovarian Research 16:1.
Crossref
Katarzyna Aneta Pankowska, Grażyna Ewa Będkowska, Joanna Chociej-Stypułkowska, Małgorzata Rusak, Milena Dąbrowska & Joanna Osada. (2023) Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance. International Journal of Molecular Sciences 24:11, pages 9279.
Crossref
Remya Raja, Christopher Wu, Esen Yonca Bassoy, Thomas E RubinoJrJr, Emma C Utagawa, Paul M Magtibay, Kristina A Butler & Marion Curtis. (2022) PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling. Journal for ImmunoTherapy of Cancer 10:12, pages e005026.
Crossref
Alicja Rajtak, Marta Ostrowska-Leśko, Klaudia Żak, Rafał Tarkowski, Jan Kotarski & Karolina Okła. (2022) Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy. Frontiers in Immunology 13.
Crossref
Esther Schoutrop, Lidia Moyano-Galceran, Stephanie Lheureux, Jonas Mattsson, Kaisa Lehti, Hanna Dahlstrand & Isabelle Magalhaes. (2022) Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Seminars in Cancer Biology 86, pages 207-223.
Crossref
Nirashaa T. Bound, Cassandra J. Vandenberg, Apriliana E. R. Kartikasari, Magdalena Plebanski & Clare L. Scott. (2022) Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system. Frontiers in Genetics 13.
Crossref
Noor Shakfa, Deyang Li, Sarah Nersesian, Juliette Wilson-Sanchez & Madhuri Koti. (2022) The STING pathway: Therapeutic vulnerabilities in ovarian cancer. British Journal of Cancer 127:4, pages 603-611.
Crossref
Shonagh Russell, Felicia Lim, Pamela N. Peters, Suzanne E. Wardell, Regina Whitaker, Ching-Yi Chang, Rebecca A. Previs & Donald P. McDonnell. (2022) Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer. Cancers 14:17, pages 4219.
Crossref
Angela M. Gocher, Creg J. Workman & Dario A. A. Vignali. (2021) Interferon-γ: teammate or opponent in the tumour microenvironment?. Nature Reviews Immunology 22:3, pages 158-172.
Crossref
Jean-David Fumet, Emilie Lardenois, Isabelle Ray-Coquard, Philipp Harter, Florence Joly, Ulrich Canzler, Caroline Truntzer, Olivier Tredan, Clemens Liebrich, Alain Lortholary, Daniel Pissaloux, Alexandra Leary, Jacobus Pfisterer, Alexandre Eeckhoutte, Felix Hilpert, Michel Fabbro, Christophe Caux, Jérôme Alexandre, Aurélie Houlier, Jalid Sehouli, Emilie Sohier, Rainer Kimmig, Bertrand Dubois, Dominique Spaeth, Isabelle Treilleux, Jean-Sébastien Frenel, Uwe Herwig, Olivia Le Saux, Nathalie Bendriss-Vermare & Andreas du Bois. (2022) Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial. Cancers 14:5, pages 1189.
Crossref
Bandar Hamad Aloufi. (2022) Structure-based Multi-targeted Molecular Docking and Molecular Dynamic Simulation Analysis to Identify Potential Inhibitors against Ovarian Cancer. Journal Of Biochemical Technology 13:2, pages 29-39.
Crossref
Marija Gjorgoska & Tea Lanišnik Rižner. (2021) Estrogens and the Schrödinger’s Cat in the Ovarian Tumor Microenvironment. Cancers 13:19, pages 5011.
Crossref
Jitka Fucikova, An Coosemans, Sandra Orsulic, David Cibula, Ignace Vergote, Lorenzo Galluzzi & Radek Spisek. (2021) Immunological configuration of ovarian carcinoma: features and impact on disease outcome. Journal for ImmunoTherapy of Cancer 9:10, pages e002873.
Crossref
Chen Zhang & Qing Yang. (2021) Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis. Frontiers in Oncology 10.
Crossref
Franklin Ning, Christopher B. Cole & Christina M. Annunziata. (2021) Driving Immune Responses in the Ovarian Tumor Microenvironment. Frontiers in Oncology 10.
Crossref
Sarah Nersesian, Sarah L. Schwartz, Stephanie R. Grantham, Leah K. MacLean, Stacey N. Lee, Morgan Pugh-Toole & Jeanette E. Boudreau. (2021) NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis. Translational Oncology 14:1, pages 100930.
Crossref
Shibai Yan, Juntao Fang, Yongcai Chen, Yong Xie, Siyou Zhang, Xiaohui Zhu & Feng Fang. (2020) Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer. BMC Cancer 20:1.
Crossref
Joanne O'Dwyer, Roisin E. O'Cearbhaill, Robert Wylie, Saoirse O'Mahony, Michael O'Dwyer, Garry P. Duffy & Eimear B. Dolan. (2020) Enhancing Delivery of Small‐Molecule‐ and Cell‐Based Therapies for Ovarian Cancer Using Advanced Delivery Strategies. Advanced Therapeutics 3:11.
Crossref
Anne M. Macpherson, Simon C. Barry, Carmela Ricciardelli & Martin K. Oehler. (2020) Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy. Journal of Clinical Medicine 9:9, pages 2967.
Crossref
Jules Russick, Carine Torset, Edouard Hemery & Isabelle Cremer. (2020) NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends. Seminars in Immunology 48, pages 101407.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.